| Literature DB >> 31498518 |
Jenni Kesäniemi1, Toni Jernfors1, Anton Lavrinienko1, Kati Kivisaari2, Mikko Kiljunen2, Tapio Mappes2, Phillip C Watts1,2.
Abstract
Wildlife inhabiting environments contaminated by radionuclides face putative detrimental effects of exposure to ionizing radiation, with biomarkers such as an increase in DNA damage and/or oxidative stress commonly associated with radiation exposure. To examine the effects of exposure to radiation on gene expression in wildlife, we conducted a de novo RNA sequencing study of liver and spleen tissues from a rodent, the bank vole Myodes glareolus. Bank voles were collected from the Chernobyl Exclusion Zone (CEZ), where animals were exposed to elevated levels of radionuclides, and from uncontaminated areas near Kyiv, Ukraine. Counter to expectations, we did not observe a strong DNA damage response in animals exposed to radionuclides, although some signs of oxidative stress were identified. Rather, exposure to environmental radionuclides was associated with upregulation of genes involved in lipid metabolism and fatty acid oxidation in the livers - an apparent shift in energy metabolism. Moreover, using stable isotope analysis, we identified that fur from bank voles inhabiting the CEZ had enriched isotope values of nitrogen: such an increase is consistent with increased fatty acid metabolism, but also could arise from a difference in diet or habitat between the CEZ and elsewhere. In livers and spleens, voles inhabiting the CEZ were characterized by immunosuppression, such as impaired antigen processing, and activation of leucocytes involved in inflammatory responses. In conclusion, exposure to low dose environmental radiation impacts pathways associated with immunity and lipid metabolism, potentially as a stress-induced coping mechanism.Entities:
Keywords: zzm321990zzm321990Myodes glareoluszzm321990zzm321990; DNA repair; RNAseq; pollution; radionuclides; stable isotope
Mesh:
Substances:
Year: 2019 PMID: 31498518 PMCID: PMC6900138 DOI: 10.1111/mec.15241
Source DB: PubMed Journal: Mol Ecol ISSN: 0962-1083 Impact factor: 6.185
Transcriptome assembly statistics
| Number of transcripts | 445,192 |
| Number of genes | 273,880 |
| GC% | 48.10 |
| Median contig length | 453 |
| Average contig length | 1,050.39 |
| N50 | 2,258 |
| Number of transcripts in E90 set | 51,173 |
| E90N50 | 2,874 |
Figure 1Summarized list of significantly enriched GO terms (FDR < 0.05) among DEGs between uncontaminated Kyiv control and CEZ populations for (a) liver and (b) spleen. GOseq results have been further reduced in REVIGO to remove overlap. GO terms are ordered by category. BP, biological pathway; CC, cell compartment; MF, molecular function and by Z‐score, which indicates the general direction of expression difference of a group of genes containing a given GO term
Differentially expressed genes in the liver and spleen. Positive fold change values indicate upregulation in bank voles inhabiting the CEZ. PPARa in parenthesis indicate known target of peroxisomal proliferator activated receptor alpha
| Gene | Function/description | Fold change (log2) |
|---|---|---|
| Liver | ||
| Metabolism and stress | ||
|
| Acyl‐CoA thioesterases, peroxisomal FAO, regulation of FA/CoA levels (PPARa) | ~1.30 |
|
| Fibroblast growth factor 21, fasting hormone (PPARa) | 2.40 |
|
| Enoyl‐CoA delta isomerase 3, peroxisomal FAO, very long chain fatty acids | 2.24 |
|
| Inhibition of glycolysis. TF | 2.05 |
|
| Regucalcin, vitamin C synthesis, Ca2+ homeostasis | 1.82 |
|
| Perilipin‐2, intracellular lipid accumulation marker (PPARa) | 1.77 |
|
| Enoyl‐CoA delta isomerase 2, mitochondrial FAO (PPARa) | 1.67 |
|
| E3 ubiquitin‐protein ligase | 1.59 |
|
| Cytochrome P450, lipid metabolism | 1.58 |
|
| G0/G1 switch protein 2, apoptosis, adipogenesis (PPARa) | 1.51 |
|
| Cytochrome P450, drug & lipid metabolism | 1.45 |
|
| Glycerol‐3‐phosphate dehydrogenase, enables gluconeogenesis from glycerol | 1.45 |
|
| Cytochrome P450, bile acid synthesis (PPARa) | 1.43 |
|
| Pyruvate dehydrogenase kinase, regulation of FAO, glycolysis and gluconeogenesis by inhibition of PDC (PPARa) | 1.41 |
|
| Retinoid (vitamin A derivate) metabolism (PPARa) | 1.34 |
|
| Cyclin‐dependent kinase 3, cell cycle regulation | 1.31 |
|
| Pantetheinase, vitamin B5 metabolism, AO activity (PPARa) | 1.27 |
|
| Peroxisomal membrane protein, peroxisome proliferation | 1.23 |
|
| Hepatic stress response TF | 1.20 |
|
| Peroxisomal FAO (PPARa) | 1.18 |
|
| Growth arrest and DNA damage‐inducible protein, DNA repair, response to DNA damage | 1.16 |
|
| Carnitine O‐palmitoyltransferase, mitochondrial FAO, rate‐limiting (PPARa) | 1.14 |
|
| Retinoid (vitamin A derivate) metabolism | 1.14 |
|
| Proline synthesis, mitochondrial, OS response | 1.14 |
|
| Fatty acid binding protein, binding and transport of intracellular FA, AO activity (PPARa) | 1.13 |
|
| Respiratory uncoupling, mitochondrial | 1.10 |
|
| Methylglutaconyl‐CoA hydratase, mitochondrial, AA degradation (ketogenic) | 1.07 |
|
| Regulation of adipocyte lipolysis (phospholipids), lipid metabolism | –1.00 |
|
| Acetyl‐CoA acetyltransferase, mevalonate pathway (cholesterol biosynthesis) | –1.10 |
|
| Cytochrome P450 | –1.14 |
|
| Angiopoietin‐like protein 8, regulation of serum TAG levels | –1.16 |
|
| Phospholipase, phospholipid synthesis | –1.17 |
|
| Cytochrome P450 | –1.22 |
|
| Lipoprotein lipase, cholesterol homeostasis | –1.25 |
|
| Cytochrome P450, drug metabolism | –1.27 |
|
| Cytochrome P450, various members, drug & lipid metabolism | ~ –1.40 |
|
| Stearoyl‐CoA desaturase 1, MUFA synthesis, rate‐limiting (PPARa) | –1.85 |
| Immune response | ||
|
| Immunity‐related GTPase, IFNg induced, innate immunity | –1.02 |
|
| Antigen peptide transporter 1, antigen processing (MHC‐I), adaptive immunity | –1.07 |
|
| Interferon‐inducible GTPase, resistance to intracellular pathogens, innate immunity | –1.07 |
|
| Glutathione S‐transferase | –1.14 |
|
| Proteasome subunit, antigen processing (MHC‐I), immunity | –1.23 |
|
| TF, immune responses | –1.25 |
|
| JAK‐STAT cascade, response to IFNs, antiviral | –1.27 |
|
| E3 ubiquitin‐protein ligase | –1.28 |
|
| Innate immunity, antiviral | –1.32 |
|
| Proteasome subunit, antigen processing (MHC‐I), immunity | –1.40 |
|
| Innate immunity, resistance to intracellular pathogens, T‐cell‐specific | –1.42 |
|
| Cytokine, chemokine receptor binding, inflammatory response | –1.43 |
|
| JAK‐STAT cascade, IFNg signaling | –1.44 |
|
| Histocompatibility antigens, antigen presenting | –1.46 |
|
| Regulation of complement cascade, immunity | –1.81 |
| Spleen | ||
| Immune response | ||
|
| Mas‐related G‐protein coupled receptor | 1.64 |
|
| Mast cell protease 8 | 1.48 |
|
| High affinity immunoglobulin epsilon receptor subunit beta, mast cell activation, IgE binding | 1.36 |
|
| Mast cell carboxypeptidase A, angiotensin metabolism | 1.35 |
|
| Transcription regulation, innate immune responses | 1.30 |
|
| Mast cell chymase, protease | 1.28 |
|
| Kininogen, inflammatory response (vasodilation) | 1.25 |
|
| Proteoglycan, cytotoxin, helminthotoxin, antiparasitic, immunity | 1.23 |
|
| Matrix metalloproteinase‐9, inflammatory response, tissue remodeling | 1.21 |
|
| Speedy protein A, cell cycle regulation, response to DNA damage | 1.14 |
|
| Haptoglobin, antimicrobial, AO, immunity | 1.11 |
|
| Innate immunity, inflammatory response, antimicrobial, AO, apoptosis | 1.11 |
|
| Neutrophil gelatinase‐associated lipocalin, antimicrobial, AO, innate immunity | 1.11 |
|
| Mast cell‐expressed membrane protein 1 | 1.10 |
|
| Arachidonate 5‐lipoxygenase, leukotriene metabolism, inflammatory response | 1.08 |
|
| Peptidoglycan recognition protein 1, antimicrobial, innate immune response | 1.07 |
|
| TF in immune and inflammatory responses | –1.01 |
|
| Ubiquitin‐conjugating enzyme E2 Q2, protein ubiquitination | –1.01 |
|
| Transcription regulation (MHC class I and MHC class II genes) | –1.03 |
|
| E3 ubiquitin‐protein ligase | –1.69 |
|
| E3 ubiquitin‐protein ligase, antigen processing | –2.04 |
| Metabolism | ||
|
| Regulation of FAO, glycolysis and gluconeogenesis | 1.57 |
|
| Fatty acid binding protein 4 | 1.47 |
|
| Lipid droplet protein perilipin | 1.27 |
|
| Angiopoietin‐related protein 4 | 1.22 |
Abbreviations: AA, amino acid; AO, antioxidant; FA, fatty acid; FAO, fatty acid oxidation; MUFA, monounsaturated fatty acid; OS, oxidative stress; PDC, pyruvate dehydrogenase complex; TAG, triacylglycerol; TF, transcription factor.
Figure 2Overview of affected liver metabolic pathways between uncontaminated control and CEZ populations of bank voles. Gene names in red colour indicate upregulation and blue colour downregulation in bank voles of the CEZ compared to control voles. ER, endoplasmic reticulum; FAO, fatty acid oxidation; VLDL, very‐low‐density lipoprotein
Figure 3Gene coexpression networks for liver and spleen. The consensus network data is filtered with p‐value (.001) and contains only links with high correlation (wTO values for liver: 0.44 for CEZ and 0.47 for Kyiv; wTO for spleen: 0.70 for CEZ and 0.72 for Kyiv). Networks were clustered with the Louvain algorithm, and the clusters are colour‐coded. The colour of the links represents the sign of the interaction, with purple links being positive and green links being negative interactions. The barplots show the proportion of categories of links† when networks from Kyiv and the CEZ were compared. CoDiNA identified 179,133 links and 2,863 nodes in the liver network, whereas 1,841,074 links and 2,960 nodes were detected in the spleen network
†α links, in both networks with the same sign (negative or positive correlation), β links, in both networks but with a different sign; γ links, specific to one network
Figure 4Carbon (δ13C) vs. nitrogen (δ15N) isotopic values for the fur samples of Myodes glareolus inhabiting the CEZ and uncontaminated locations near Kyiv (with mean values of each group in the centre), and their potential dietary sources. Fur isotopic values were corrected downwards (by factors of 2.2‰ for δ13C and 2.8‰ for δ15N, see Kurle et al., 2014) to account for differences between isotopic values of animal tissue and food sources. Dietary sources‡ are presented with means and SD
‡FN, fungi; HP, herbaceous plants; IN, insects; LI, lichens; MO, mosses; WP, woody plants